profit from every $100 of sales.
$0$100
Psyence Biomedical Ltd. Warrant
$0.02+6.67% today
-47.0% in 1 year
1-year low $0.011-year high $0.04
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $3.14 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Psyence Biomedical Ltd. Warrant sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with $1.01 million of profit last year.
SalesProfit
Psyence Biomedical Ltd. Warrant vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Psyence Biomedical Ltd. Warrant | 3.1× · No profit yet | ||
 Vertex Pharmaceuticals | 34.5× · Expensive | ||
 Regeneron Pharmaceuticals | 21.9× · Fair price | ||
 Moderna | No profit yet | ||
 CSL | 22.0× · Fair price |
AI analysis
An AI analyst reads Psyence Biomedical Ltd. Warrant's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -2 | -3 | -44 | -4 | |
| -2 | -3 | -51 | 1 | |
| -2 | -3 | -51 | 1 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2 | 2 | 1 | 7 |
| Cash | 2 | 1 | 1 | 6 |
| Total debt | – | – | 10 | – |
| Total liabilities | 0 | 2 | 12 | 1 |
| 2 | -0 | -11 | 7 | |
| – | – | – | – | |
| -86.2% | – | – | 12.0% | |
| -109.3% | 1,599.6% | 466.2% | 15.1% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -1 | -2 | -3 | -4 | |
| – | – | 0 | 0 | |
| -1 | -2 | -3 | -4 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 0 | 0 | 0 | 0 |
Valuation
- 3.1×
- –
- 0.03
- 0.5×
- 0.0×
- –
- –
- -178,121.6%
- 31.9%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -54.5%
- 2,443.2%
- -47.6%
- 13.8%
- -54.5%
- –
Growth
- –
- +92.4%
- −26.9%
- –
- −74.1%
Financial health
- -6.0×
- 0.00
- 0.0%
- -395.1×
- 11.04
- 11.04
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 5%of 952
Bottom 20%of 884
Top 1%of 601
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
50No pass
Benjamin Graham
87Pass
Philip Fisher
55No pass
Peter Lynch
93Pass
Joel Greenblatt
62Pass
Charlie Munger
47No pass
Terry Smith
44No pass
Questions about Psyence Biomedical Ltd. Warrant
Is Psyence Biomedical Ltd. Warrant a good stock to buy?
A business with weak numbers that is not profitable yet. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Psyence Biomedical Ltd. Warrant AI analysis
What does Psyence Biomedical Ltd. Warrant do?
Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. It is in Biotechnology.
Does Psyence Biomedical Ltd. Warrant pay a dividend?
No. Psyence Biomedical Ltd. Warrant does not pay a dividend at the moment.
How has Psyence Biomedical Ltd. Warrant stock done over the past year?
Down 47.0% over the past twelve months, to $0.02. It traded between $0.01 and $0.04 and is 54.3% below its high.
Who are Psyence Biomedical Ltd. Warrant's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and CSL. The peers table on this page compares their profit, growth and price with Psyence Biomedical Ltd. Warrant's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.